Innovation Pharmaceuticals Inc (IPIX)

[cabel]

There was a reason why I asked about CTIX's plan for ASCO 2014. If CTIX were to present new clinical data, the anticipation of Kevetrin news would certainly help put a floor under the share price and may even result in share price appreciation leading up to ASCO. Because whether you like it or not the share price will experience pull back post ASCO. If you do not believe me, pull up CTIX's graph for June 2013. Sub $1.25s will be here before you know it in absence of any significant news. I want to go long but I will wait for post ASCO pullback.


Good luck with that,... It would be best to look at all the possible PR's between now and May 30th.

- Cohort - 8 advancement
- Start of B (OM)
- End of Prurisol Phase 1
- B (ABSSSI) 50% complete
- Start of UofB
- Misc unforseen news,.. Leo always has something up his sleeve!